Radiotherapy and Oncology

Papers
(The H4-Index of Radiotherapy and Oncology is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
The long-term impact of irradiation on functional connectivity in brain circuits involved in memory processes after pediatric posterior fossa tumor130
OC-0088 Reduced tube feeding dependence by continuous improvements in head and neck radiotherapy104
Whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)96
Definitive chemoradiotherapy versus esophagectomy in patients with clinical T1bN0M0 esophageal squamous cell carcinoma: A retrospective study94
PO-1577 Evaluation of a new Automated TLD Reader for silica bead radiotherapy dosimetry91
Contents82
Corrigendum to “DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1α, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma p78
2486: Impact of patient specific deep learning OAR segmentation on accumulated online adapted MRgRT dose76
687: Hearing loss after cranial radiation in children: a dosimetry study from the French registry PediaRT69
1861: Performance of a heart substructures autocontouring tool after clinical implementation69
3201: Dosimetric properties of flexible 3D-printed boluses68
1933: High-resolution Diode array vs film for QA of trigeminal neuralgia treatments with Cyberknife68
937: Prediction of the dose-averaged proton linear energy transfer using convolutional neural networks67
2076: RapidBrachyIVBT: A dosimetry software for personalized image-guided intravascular brachytherapy67
3050: Impact of a philanthropic online course about cervical cancer on the learning outcome64
3007: SABR prior to liver transplantation in HCC patients: a 10 years’ experience64
1086: Urethra-sparing single-dose ablative prostate radiotherapy with real-time motion management57
2030: Impact & usability of virtual reality on emotional wellbeing of sarcoma patients:VR-SARC study57
158: Validation of intrafraction prostate drift corrections on a 1.5T MR-linac using cine-MRI57
1583: Phantom-based optimization of virtual monoenergetic image reconstruction in dual-energy CT55
3429: Modulating innate immunity by DNA damage response inhibition53
1062: Micro-dissected tumour tissues-on-chip; a tool for translational radiation oncology51
1232: Modern era radical radiotherapy toxicity: a preliminary CONCORDE analysis of the calibration arm51
749: Reinforcement learning for accelerated automatic treatment planning optimization51
204: PET-CT DenseNet outperforms advanced DL models for outcome prediction of oropharyngeal cancer50
1635: In vivo dosimetry - keeping my finger on the pulse47
2011: Physical & psychosocial effects of radical chemoradiotherapy for cervix cancer: a systematic review47
2975: UHRT in PCa: a clinical and toxicity impact analysis from real world experience.47
910: Comparison of Eclipse and RayStation in Multi-Criteria Optimization in Prostate Cancer Radiotherapy47
2605: HDR brachytherapy boost plus EBRT in unfavorable prostate cancer: results in more then 700 patients46
2578: Respiratory gating with CPAP in left breast cancer RT: preliminary results of a prospective study44
1664: Assessing overall and fractional CTV coverage in breast cancer radiotherapy based on daily imaging43
895: Predicting Overall Survival for Patients Who Underwent Adjuvant Chemoradiotherapy for Gastric Cancer43
360: The role of SGRT in detecting inter and intra fraction errors in SBRT treatments to the lung43
2489: Endothelial senescence primes aggressiveness of glioblastoma cells after radiotherapy43
941: Should Varian HyperArc make us re-think how we use conventional linacs for SRS?42
1962: Study protocol B-REST: respiratory und relaxation training in adjuvant radiotherapy of breast cancer40
2607: Carbon footprint reduction with the adoption of hypofractionation in a public health facility40
2311: Treatment plan robustness in IMPT for esophageal cancer: every millimeter counts.39
0.066709995269775